REEV, a Boston, MA- and Toulouse, France-based medical technology startup, raised $9.2M in funding.
The round was led by Newfund Heka, Polytechnique Ventures and Irdi Capital, with participation from Techstars and a group of business angels and health care operators. Contributors included French soccer player Raphael Varane and knee surgeon Herve Silbert, assembled by Scala Patrimoine, a multi-family office.
The company intends to sue the funds to finalize DREEVEN’s design, conducting a clinical study at the Neuromotor Recovery Lab at Boston University’s Sargent College of Health and Rehabilitation Sciences under the leadership of Dr. Lou Awad, and prepare for U.S. Food and Drug Administration trials.
Founded in 2021 by Amaury Ciurana (CEO) and Dr. Robin Temporelli (CTO), REEV is a medtech startup dedicated to enhancing mobility assistance. By developing intelligent, lightweight wearable robotics, the company aims to improve quality of life for patients with difficulty walking, helping them regain independence and mobility.
The tech portfolio includes two key solutions:
— REEV SENSE, a motion sensor system that attaches to a patient’s shoe or leg, delivering precise gait analysis.
— DREEVEN, a wearable robotics system using electro-hydraulic technology to provide personalized knee assistance.
FinSMEs
06/02/2025